2.48
price up icon2.06%   0.05
 
loading

Veru Inc (VERU) 最新ニュース

pulisher
Apr 12, 2026

Veru Q1 2026 earnings preview - MSN

Apr 12, 2026
pulisher
Apr 12, 2026

Q1 2026 Veru Inc Earnings Call Transcript - GuruFocus

Apr 12, 2026
pulisher
Apr 10, 2026

Aug Breakouts: What is the earnings history of Veru IncEarnings Beat & Safe Entry Point Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 07, 2026

Veru Inc May Offer Up To $200 Million Of Securities From Time To Time - TradingView — Track All Markets

Apr 07, 2026
pulisher
Apr 07, 2026

Veru Inc. (NASDAQ: VERU) registers $200M shelf for stock, debt and warrants - Stock Titan

Apr 07, 2026
pulisher
Apr 07, 2026

Veru Inc. (NASDAQ: VERU) registers 23.8M shares from Oct 2025 warrants - Stock Titan

Apr 07, 2026
pulisher
Apr 04, 2026

Veru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trial - MSN

Apr 04, 2026
pulisher
Apr 02, 2026

MACD Signal: Is Veru Inc benefiting from innovation trendsWeekly Profit Summary & Free Community Consensus Stock Picks - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 02, 2026

Veru SEC Filings - Stock Titan

Apr 02, 2026
pulisher
Mar 30, 2026

Veru Inc. (VERU) Stock Price Quote Today & Current Price Chart - Capital.com

Mar 30, 2026
pulisher
Mar 27, 2026

Veru (NASDAQ:VERU) Shares Cross Below 200 Day Moving Average – Here’s Why - Defense World

Mar 27, 2026
pulisher
Mar 26, 2026

FRA:FMW0 PB Ratio: 1.74 — 41% Below Median - GuruFocus

Mar 26, 2026
pulisher
Mar 25, 2026

Veru outlines Phase III plans for enobosarm and signals upcoming FDA clarity on lean mass preservation in obesity treatment - MSN

Mar 25, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Veru (VERU) - Stock Titan

Mar 22, 2026
pulisher
Mar 21, 2026

Volume Recap: Is Veru Inc attractive for institutional investors2026 Volume & Weekly High Return Stock Forecasts - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 14, 2026

Veru Inc. Amends 2018 Equity Incentive Plan and Reports Annual Meeting Results – Form 8-K Filing March 12, 2026 - Minichart

Mar 14, 2026
pulisher
Mar 13, 2026

Veru Shareholders Expand Equity Plan, Reelect Board Leadership - TipRanks

Mar 13, 2026
pulisher
Mar 13, 2026

Veru (NASDAQ: VERU) investors back larger equity plan, board slate and auditor - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

Aug Macro: Is Veru Inc attractive for institutional investors2026 Opening Moves & Daily Market Momentum Tracking - baoquankhu1.vn

Mar 13, 2026
pulisher
Mar 11, 2026

Veru Inc. (NASDAQ: VERU) Q1 2026 earnings call transcript - MSN

Mar 11, 2026
pulisher
Mar 10, 2026

Veru Targets GLP-1 Muscle Loss Risk With New Enobosarm Combo Study - TipRanks

Mar 10, 2026
pulisher
Mar 09, 2026

Veru enrolls first patient in obesity drug combination trial By Investing.com - Investing.com Canada

Mar 09, 2026
pulisher
Mar 09, 2026

Veru (VERU) Launches Phase 2b Trial for Obesity Treatment - GuruFocus

Mar 09, 2026
pulisher
Mar 09, 2026

Veru enrolls first patient in Phase 2b PLATEAU trial of enobosarm - TipRanks

Mar 09, 2026
pulisher
Mar 09, 2026

Veru enrolls first patient in obesity drug combination trial - Investing.com Australia

Mar 09, 2026
pulisher
Mar 09, 2026

Veru Inc. Initiates Phase 2b Clinical Trial for Enobosarm to Enhance Weight Loss in Older Patients with Obesity Receiving Semaglutide - Quiver Quantitative

Mar 09, 2026
pulisher
Mar 09, 2026

Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss - Yahoo Finance

Mar 09, 2026
pulisher
Mar 09, 2026

Veru tests add-on pill to preserve muscle during Wegovy weight loss - Stock Titan

Mar 09, 2026
pulisher
Mar 06, 2026

VERU Earnings History & Surprises | EPS & Revenue Results | VERU INC (NASDAQ:VERU) - ChartMill

Mar 06, 2026
pulisher
Mar 03, 2026

Veru Inc. (VERU) Presents at Oppenheimer 36th Annual Healthcare Life Sciences ConferenceSlideshow - Seeking Alpha

Mar 03, 2026
pulisher
Mar 02, 2026

Veru : Corporate Presentation, February 2026 - marketscreener.com

Mar 02, 2026
pulisher
Feb 28, 2026

VERU Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

VERU Should I Buy - Intellectia AI

Feb 27, 2026
pulisher
Feb 26, 2026

Veru at Oppenheimer Conference: Strategic Insights into Obesity Drug Development - Investing.com

Feb 26, 2026
pulisher
Feb 26, 2026

VERU PE Ratio & Valuation, Is VERU Overvalued - Intellectia AI

Feb 26, 2026
pulisher
Feb 19, 2026

Aug Volume: Is CHGG vulnerable to short sellersJuly 2025 Volume & Expert Curated Trade Setup Alerts - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 19, 2026

Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Bitget

Feb 19, 2026
pulisher
Feb 16, 2026

Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave - Intellectia AI

Feb 16, 2026
pulisher
Feb 15, 2026

Will Veru Inc. benefit from sector rotationWeekly Trend Summary & Long-Term Capital Growth Strategies - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Aug Closing: Can PIII outperform under higher oil pricesAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 13, 2026

VERU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 13, 2026
pulisher
Feb 13, 2026

Earnings call transcript: Veru Inc. Q1 2026 sees stock rise amid strategic shifts - Investing.com Nigeria

Feb 13, 2026
pulisher
Feb 12, 2026

Veru outlines new Phase IIb obesity trial and targets interim analysis in Q1 2027 while increasing cash reserves - MSN

Feb 12, 2026
pulisher
Feb 12, 2026

Veru Inc. (NASDAQ:VERU) Q1 2026 Earnings Call Transcript - Insider Monkey

Feb 12, 2026
pulisher
Feb 11, 2026

Veru Q1 2026 Earnings Call Transcript - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Veru Inc. Charts Risky but Clearer Post-GLP-1 Path - TipRanks

Feb 11, 2026
pulisher
Feb 11, 2026

Veru Inc (VERU) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada

Feb 11, 2026
pulisher
Feb 11, 2026

Veru Inc. (VERU) Advances Clinical Pipeline with Enobosarm and S - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Veru Inc (VERU) Q1 2026 Earnings Call Highlights: Strategic Adva - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

VERU INC. SEC 10-Q Report - TradingView

Feb 11, 2026
pulisher
Feb 11, 2026

VERU: No revenue, $5.3M net loss, $33M cash, strategic shift to drug development, going concern risk - TradingView

Feb 11, 2026
pulisher
Feb 11, 2026

Earnings call transcript: Veru Inc. Q1 2026 sees stock rise amid strategic shifts By Investing.com - Investing.com South Africa

Feb 11, 2026
pulisher
Feb 11, 2026

Veru (VERU) Q1 2026 Earnings Call Transcript - The Globe and Mail

Feb 11, 2026
$53.49
price down icon 1.36%
$48.32
price down icon 0.72%
$100.95
price up icon 1.40%
$150.02
price down icon 1.57%
$143.40
price down icon 2.37%
ONC ONC
$320.18
price up icon 0.08%
大文字化:     |  ボリューム (24 時間):